![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication December 22, 2004.
Revised February 4, 2005.
Accepted for publication February 8, 2005.
signaling mediates
inhibition of hypoxia-induced necrosis of cortical
neurons
Ischemic stress causes neuronal death and functional
impairment. Previous evidence has suggested that cells
in the ischemic core lose viability first due to the
decline in blood flow and cellular energy metabolism,
and die by necrosis. Although inhibition of necrosis
could be a potent therapeutic target for brain ischemia,
known neurotrophic factors are ineffective for neuronal
necrosis. In a previous study, we found that insulin,
but not BDNF or IGF-1, inhibited neuronal necrosis under
serum-free starvation stress. Although insulin
receptors are abundant in the central nervous system as
well as in peripheral tissues, neurons are not dependent
upon insulin for their glucose supply, indicating that
insulin receptors have other roles in the central
nervous system. In the present study using hypoxia-
reperfusion stress, cortical neurons rapidly died by
necrosis as evaluated by propidium iodide staining and
transmission electron microscopic analysis. As
expected, insulin treatment significantly inhibited
neuronal necrosis and this effect was blocked by
pretreatment with an antisense oligonucleotide for the
insulin receptor. Furthermore, an inhibitor of protein
kinase C (PKC) eliminated the insulin-induced anti-
necrotic effect. The addition of insulin induced
significant translocation of only the PKC-
isoform, and antisense oligonucleotide treatment for
this isoform abolished the insulin-induced inhibition of
necrosis. Taken together, these results suggest that
insulin mediates inhibition of neuronal necrosis through
a novel mechanism involving PKC-
activation.
Key words:
PKC-
, cortex, hypoxia-reperfusion, insulin receptor, necrosis, propidium iodide